FDANonrulemakingFDA-2023-D-0044
Who commented on this docket
Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA; Draft Guidance for Industry; Availability
1 organizations filed 1 public comment on Product-Specific Guidance Meetings Between FDA and ANDA Applicants Under GDUFA; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1191d ago.
Organizations
1
Comments
1
RIN
—
Comment window
closed 1191d ago
Abstract
Open
Commenters (1)
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%
Attribution is name-based and imperfect. regulations.gov data is public record.